AI assistant
Sending…
Beam Therapeutics Inc. — Director's Dealing 2021
Nov 9, 2021
31533_dirs_2021-11-08_b25e7b48-2e9e-4ff7-8d87-b2250b3675f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2021-11-05
Reporting Person: MARAGANORE JOHN (Director)
More from Beam Therapeutics Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Director's Dealing
2026
Feb 26
Annual Report
2026
Feb 24
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 12
Major Shareholding Notification
2026
Feb 5
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Feb 5
Major Shareholding Notification
2026
Feb 3